This article provides a foundational and practical guide for researchers, scientists, and drug development professionals on designing and implementing robust aseptic process simulation (APS) programs for autologous cell therapies.
This article provides a comprehensive analysis of the in vivo persistence of autologous versus allogeneic therapeutic cells, a critical determinant of efficacy in regenerative medicine and oncology.
This article provides a comprehensive guide to process validation for autologous cell therapy manufacturing, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive comparative assessment of autologous and allogeneic invariant Natural Killer T (iNKT) cells for adoptive immunotherapy.
This comprehensive review addresses the critical challenge of T cell exhaustion in autologous cell therapy products, which significantly limits treatment efficacy in cancer immunotherapy.
Autologous cell therapies represent a transformative medical advancement, yet their high manufacturing costs severely limit patient access and commercial viability.
This article provides a comprehensive analysis of the unique challenges and innovative solutions in managing supply chains for autologous cell and gene therapies.
This article provides a comprehensive overview of leukapheresis processing, a critical initial step in autologous cell therapy manufacturing.
This article provides a comprehensive overview of the current state of ex vivo expansion protocols for autologous cells, a critical process for cell therapies in immuno-oncology, autoimmunity, and hematopoietic transplantation.
This article provides researchers, scientists, and drug development professionals with a comprehensive guide to the specialized software platforms essential for modern cell therapy manufacturing.